Clinical trials
Phase 3 Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2012 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Vertex Pharmaceuticals Incorporated | 3 |
| Lipomed | 1 |
| Novartis | 1 |
| Novo Nordisk A/S | 1 |
| University of Campinas, Brazil | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 11 |
| beta-Thalassemia | 5 |
| Anemia, Sickle Cell | 4 |
| Iron Overload | 4 |
| Anemia | 3 |
| Genetic Diseases, Inborn | 3 |
| Hematologic Diseases | 3 |
| Hemoglobinopathies | 3 |
| Anemia, Diamond-Blackfan | 2 |
| Hemosiderosis | 2 |
Trials
Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.